• Contact Us


    • Plant 3

      OSD and Injectable Oncology - Verna, Goa - Installation completed and under process validation

      2019-04-08 14:55:31

    • Plant 2

      OSD - Skidel, Belarus Inaugurated on 7-Mar-19. Commercial Licence Obtained in Dec-2019

      2020-01-25 10:12:34

    • Plant 4

      ONCO API, Goa - Building is ready, machine installations in progress

      2019-09-24 17:49:06

    • Fight against Covid-19

      Face mask, Two Yard distance and hand wash is must

      2020-10-16 14:21:39

    • DSIR Approved R&D Centre

      R&D and ADL centre has certified by DSIR, Govt. of India.

      2020-10-16 14:22:49


    • Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg  And  Favipiravir 200 mg/400mg/800mg Tablet.

    • Lok-Beta has independent Research & Development facility approved by DSIR, Government of India. 
    • Development new formulation in different segment of niche molecules equipped with well qualified personnel supported by latest technology and machine. Spread over separate 650 Sq. M. block.
    •  R&D and ADL has bright future and lot of new latest non patented molecules are under development and the same will be commercialized in a upcoming six months.
    • Lok-Beta niche molecules such as Antiretroviral, Immunosuppressant, Urological, Antihypertensive, Anti diabetics and Anti Tuberculosis are aim is to provide /develop new formulation and application for the human well-being.
    • Lok-Beta developed more than 40 Niche molecules and rigorously planning for develop @10 new core products yearly